Feed CELZ
CE

Creative Medical Technology Holdings, Inc. CELZ · NASDAQ

$0.74 -4.39% (-$0.03)

Market cap
$1.87M
Enterprise value
-$6.85M
P/E
-
Forward P/E
-
PEG
-
P/S
622.5x
P/FCF
-
EV/EBITDA
-
ROIC
-71.9%
Gross margin
-1,732.4%
Net margin
-201,355.0%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-
Beta
1.91
Free float
92.4%

About the company

Creative Medical Technology Holdings, Inc. (CELZ) shares could be suitable for investors looking to invest in the biotechnology and regenerative medicine sector. The company's focus on research and development of therapeutic solutions for the treatment of various diseases positions it as a key player in the field of biotechnology and regenerative medicine. Known for its efforts to harness modern technologies to support tissue self-regeneration and treat chronic illnesses, Creative Medical Technology Holdings, Inc. aims to provide innovative treatment options and enhance the quality of life for patients.

Sector

Healthcare

Industry

Biotechnology

CEO

Timothy Warbington

Employees

4

Headquarters

Phoenix

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy